Navigation Links
Brookdale to Present at JMP Securities Healthcare Focus Conference
Date:10/2/2009

NASHVILLE, Tenn., Oct. 2 /PRNewswire-FirstCall/ -- Brookdale Senior Living Inc. (NYSE: BKD) today announced that Mark Ohlendorf, Co-President and Chief Financial Officer, will make a presentation regarding the Company at the JMP Securities Healthcare Focus Conference in New York, New York on Monday, October 5, 2009, beginning at 3:30 p.m. Eastern Time.

The presentation is being audio webcast live and can be accessed on the Internet at http://www.wsw.com/webcast/jmp9/bkd/ as well as through the Investor Relations section of the Company's website at www.brookdaleliving.com. A replay of the webcast will be available on the Company's website for 30 days after the date of the presentation. The presentation slides will also be available during and after the presentation through the Investor Relations section of the Brookdale Senior Living website.

About Brookdale Senior Living

Brookdale Senior Living Inc. is a leading owner and operator of senior living communities throughout the United States. The Company is committed to providing an exceptional living experience through properties that are designed, purpose-built and operated to provide the highest-quality service, care and living accommodations for residents. Currently the Company owns and operates independent living, assisted living, and dementia-care communities and continuing care retirement centers, with 546 communities in 35 states and the ability to serve approximately 52,000 residents.

SOURCE Brookdale Senior Living Inc.


'/>"/>
SOURCE Brookdale Senior Living Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Brookdale Announces Second Quarter 2009 Release and Earnings Call
2. Brookdale Announces Completion of Follow-On Offering
3. Brookdale to Present at JMP Securities Research Conference
4. Brookdale to Present at Bank of America and Merrill Lynch 2009 Health Care Conference
5. Brookdale Announces First Quarter 2009 Results; CFFO of $0.49 per Share
6. Brookdale Announces First Quarter 2009 Release and Earnings Call
7. Brookdale to Present at Barclays Capital Global Healthcare Conference March 11
8. Brookdale Announces Fourth Quarter and Full Year 2008 Results
9. Brookdale Amends and Extends Corporate Line of Credit
10. Brookdale Announces Fourth Quarter 2008 Release and Earnings Call
11. Brookdale to Present at UBS Global Healthcare Services Conference February 10
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology: